Search Within

Mohammad Meenhaj Uddin

Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (8)
  2. GSK Faculty (8)
  3. Hematologic Malignancies Research (8)
  4. Molecular Pharmacology and Chemistry Program Faculty (8)
  5. Sloan Kettering Institute Faculty (8)
  6. Sloan Kettering Institute Postdocs (7)

More Groups

People
  1. Gabriela Chiosis (8)
  2. Tony Taldone (7)
  3. Mark Dunphy (6)
  4. Shanu Modi (6)
  5. Jason Lewis (5)
  6. John Gerecitano (5)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2015 (2)
  4. 2014 (1)
  5. 2013 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Journal of Medicinal Chemistry (1)
  6. Journal of Visualized Experiments (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. American Chemical Society (1)
  4. Cell Press (1)
  5. MYJoVE Corporation (1)
  6. Nature Publishing Group (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Journal Article

    Inda, M. C.; Joshi, S.; Wang, T.; Bolaender, A.; Gandu, S.; Koren, J. 3rd; Che, A. Y.; Taldone, T.; Yan, P.; Sun, W.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeutics
    Journal Article

    Corben, A. D.; Uddin, M. M.; Crawford, B.; Farooq, M.; Modi, S.; Gerecitano, J.; Chiosis, G.; Alpaugh, M. L.
    Journal of Visualized Experiments (2014)

    Fulltext@MSK | Save
  • Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series
    Journal Article

    Taldone, T.; Patel, P. D.; Patel, M.; Patel, H. J.; Evans, C. E.; Rodina, A.; Ochiana, S.; Shah, S. K.; Uddin, M.; Gewirth, D.; more...
    Journal of Medicinal Chemistry (2013)

    Fulltext@MSK | Save